Yidu Tech Inc. (HKG:2158)
Hong Kong · Delayed Price · Currency is HKD 6.46
-0.06 (-0.92%)
Aug 7, 2025, 4:08 PM HKT
CEQP Revenue
In the fiscal year ending March 31, 2025, Yidu Tech had annual revenue of 714.98M CNY, down -11.41%. Yidu Tech had revenue of 385.53M in the half year ending March 31, 2025, with 16.71% growth.
Revenue
714.98M CNY
Revenue Growth
-11.41%
P/S Ratio
8.91
Revenue / Employee
868.75K CNY
Employees
823
Market Cap
6.83B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 714.98M | -92.10M | -11.41% |
| Mar 31, 2024 | 807.08M | 2.38M | 0.30% |
| Mar 31, 2023 | 804.70M | -432.50M | -34.96% |
| Mar 31, 2022 | 1.24B | 370.16M | 42.69% |
| Mar 31, 2021 | 867.04M | 308.95M | 55.36% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |